Evidence map›Paper›PMID 37214422›Full record

ArticleFrontiers in genetics2023

Functional mapping of microRNA promoters with dCas9 fused to transcriptional regulators.

Pradeep Kumar, Mathilde Courtes, Céline Lemmers, Anne Le Digarcher, Ilda Coku, Arnaud Monteil, Charles Hong, Annie Varrault, Runhua Liu, Lizhong Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. CRISPR-Activation: Boosting Expression of Plant MIRs.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Pradeep KumarDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.
Mathilde CourtesInstitut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France.
Céline LemmersPlateforme de Vectorologie de Montpellier (PVM), BioCampus Montpellier, CNRS, INSERM, Université de Montpellier, Montpellier, France.
Anne Le DigarcherInstitut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France.
Ilda CokuInstitut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France.
Arnaud MonteilPlateforme de Vectorologie de Montpellier (PVM), BioCampus Montpellier, CNRS, INSERM, Université de Montpellier, Montpellier, France.
Charles HongVanderbilt University School of Medicine Nashville, Nashville, TN, United States.
Annie VarraultDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.
Runhua LiuDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.
Lizhong WangDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.
Tristan BouschetInstitut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France.
University of Alabama at Birmingham · USCentre National de la Recherche Scientifique · FRUniversité de Montpellier · FRInserm · FRInstitut de Génomique Fonctionnelle · FRVanderbilt University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs are small non-coding RNAs that control gene expression during development, physiology, and disease. Transcription is a key factor in microRNA abundance and tissue-specific expression. Many databases predict the location of microRNA transcription start sites and promoters. However, these candidate regions require functional validation. Here, dCas9 fused to transcriptional activators or repressors - CRISPR activation (CRISPRa) and inhibition (CRISPRi)- were targeted to the candidate promoters of two intronic microRNAs, mmu-miR-335 and hsa-miR-3662, including the promoters of their respective host genes Mest and HBS1L. We report that in mouse embryonic stem cells and brain organoids, miR-335 was downregulated upon CRISPRi of its host gene Mest. Reciprocally, CRISPRa of Mest promoter upregulated miR-335. By contrast, CRISPRa of the predicted miR-335-specific promoter (located in an intron of Mest) did not affect miR-335 levels. Thus, the expression of miR-335 only depends on the promoter activity of its host gene Mest. By contrast, miR-3662 was CRISPR activatable both by the promoter of its host gene HBS1L and an intronic sequence in HEK-293T cells. Thus, CRISPRa and CRISPRi are powerful tools to evaluate the relevance of endogenous regulatory sequences involved in microRNA transcription in defined cell types.

Indexed as

CRISPRaCRISPRiembryonic stem (ES) cellMest/PEG1microRNAmiR-335miR-3662promoter

Identifiers

PMID37214422
PMCPMC10196145
OpenAlexW4377208812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.